What stops naloxone and supervised injection facilities being implemented across Ireland?

What is it about?

Opioid drug-related deaths are a serious and persistent public health problem in both the Republic of Ireland and Northern Ireland, yet the two regions differ significantly in their harm reduction infrastructure. Naloxone distribution has been implemented in both jurisdictions, but supervised injection facilities (SIFs) remain absent across the island. This qualitative study explored the social and policy barriers and facilitators that shape the implementation of naloxone programmes and supervised injection facilities in both parts of Ireland. Findings identified stigma and community objections as shared barriers to both interventions, with paramilitary coercion and intimidation emerging as a distinctive and serious barrier specifically affecting people who use drugs in Northern Ireland. Peer-to-peer naloxone distribution was identified as a key facilitator, with the research finding that naloxone programmes empower communities when delivered through low-threshold harm reduction contexts. The study concludes that multilevel stigma reduction campaigns are a necessary precondition for successful SIF implementation.

Featured Image

Why is it important?

Ireland's island-wide context presents a unique natural experiment in harm reduction policy, with two jurisdictions sharing a border, similar drug use patterns and comparable death rates, but different legal frameworks, health systems and political environments. The identification of paramilitary coercion as a specific barrier to harm reduction engagement in Northern Ireland is a finding with no equivalent in the wider international literature and has significant implications for service design and safety planning for people who use drugs in conflict-affected communities. The paper contributes directly to the evidence base informing SIF policy debates on the island of Ireland. The multilevel stigma finding aligns with the realist review on naloxone mechanisms (Miller et al., 2022) and reinforces the case that stigma is not merely an attitudinal problem but a structural barrier requiring coordinated policy responses.